Search
Balchem Corp
BCPCAdd to Watchlist
168.800USD
-0.090-0.05%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
5.42BMarket Cap
34.32P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-0.05%
5 Days
-0.25%
1 Month
+7.30%
6 Months
+9.60%
Year to Date
+10.07%
1 Year
+3.43%
Key Figures
169.660Open
170.335High
196.06KVolume
34.32P/E TTM
27.87P/E Dynamic
0.960Dividend TTM
0.61%Turnover Ratio
168.890Prev. Close
167.050Low
26.62MTurnover
42.21P/E Static
4.22P/B
0.57%Div Yield TTM
9.55%ROA
183.90052wk High
0.95Volume Ratio
128.47MNet Profit
32.13MShares
4.9184EPS TTM
0.84Beta
12.68%ROE
139.17052wk Low
1.95%Amplitude
37.34%Gross Margin
5.42BMarket Cap
6.36Reward/Risk
1.23%Risk Rate
TradingKey Stock Score of Balchem Corp
Currency: USD Updated: 2026-07-02Key Insights
Balchem Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 11 out of 67 in the Chemicals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 200.75.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Balchem Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Balchem Corp Highlights
StrengthsRisks
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.04B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 22.16%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 22.16%.
Fairly Valued
The company’s latest PB is 4.22, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 28.38M shares, decreasing 6.62% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.65.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
200.750
Target Price
+18.64%
Upside Space
Balchem Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Balchem Corp Info
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Ticker SymbolBCPC
CompanyBalchem Corp
CEOHarris (Theodore L)
Website
Related Instruments
+2.45%
+1.72%
+1.76%
+2.54%
+2.72%
+2.33%
+2.20%
+2.55%
+1.48%
+2.21%
-0.40%
+0.84%
-3.33%
-4.59%
-2.10%
+2.68%
+2.70%
+2.63%
+0.22%
-0.92%Popular Instruments
52857.400
+14.900 (+0.03%)
29678.900
+367.500 (+1.25%)
7508.400
+36.900 (+0.49%)
14971.000
+168.000 (+1.14%)
69746.000
+1598.000 (+2.35%)
6417.000
+64.200 (+1.01%)
68.423
+0.079 (+0.12%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4169.790
+47.880 (+1.16%)
FAQs
What is the current price of Balchem Corp (BCPC)?
The current price of Balchem Corp (BCPC) is 168.80.
What is the symbol of Balchem Corp?
The ticker symbol of Balchem Corp is BCPC.
What is the 52-week high of Balchem Corp?
The 52-week high of Balchem Corp is 183.90.
What is the 52-week low of Balchem Corp?
The 52-week low of Balchem Corp is 139.17.
What is the market capitalization of Balchem Corp?
The market capitalization of Balchem Corp is 5.42B.
Is Balchem Corp (BCPC) currently rated as Buy, Hold, or Sell?
According to analysts, Balchem Corp (BCPC) has an overall rating of Buy, with a price target of 200.75.
What is the Earnings Per Share (EPS TTM) of Balchem Corp (BCPC)?
The Earnings Per Share (EPS TTM) of Balchem Corp (BCPC) is 4.80.